img

Global Animal Pharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal Pharmaceutical Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Animal Pharmaceutical market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Animal Pharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Animal Pharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Animal Pharmaceutical is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Animal Pharmaceutical include Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Virbac, Ceva Sante Animale and Vétoquinol, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Animal Pharmaceutical, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Animal Pharmaceutical by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Animal Pharmaceutical market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Animal Pharmaceutical market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
Vétoquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
By Type
Vaccine
Veterinary Drugs
Other
By Application
Companion Animal
Poultry
Other
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Animal Pharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Pharmaceutical sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Animal Pharmaceutical Definition
1.2 Market by Type
1.2.1 Global Animal Pharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Vaccine
1.2.3 Veterinary Drugs
1.2.4 Other
1.3 Market Segment by Application
1.3.1 Global Animal Pharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Companion Animal
1.3.3 Poultry
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Animal Pharmaceutical Sales
2.1 Global Animal Pharmaceutical Revenue Estimates and Forecasts 2018-2034
2.2 Global Animal Pharmaceutical Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Animal Pharmaceutical Revenue by Region
2.3.1 Global Animal Pharmaceutical Revenue by Region (2018-2024)
2.3.2 Global Animal Pharmaceutical Revenue by Region (2024-2034)
2.4 Global Animal Pharmaceutical Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Animal Pharmaceutical Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Animal Pharmaceutical Sales Quantity by Region
2.6.1 Global Animal Pharmaceutical Sales Quantity by Region (2018-2024)
2.6.2 Global Animal Pharmaceutical Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Animal Pharmaceutical Sales Quantity by Manufacturers
3.1.1 Global Animal Pharmaceutical Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Animal Pharmaceutical Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Animal Pharmaceutical Sales in 2022
3.2 Global Animal Pharmaceutical Revenue by Manufacturers
3.2.1 Global Animal Pharmaceutical Revenue by Manufacturers (2018-2024)
3.2.2 Global Animal Pharmaceutical Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Animal Pharmaceutical Revenue in 2022
3.3 Global Animal Pharmaceutical Sales Price by Manufacturers
3.4 Global Key Players of Animal Pharmaceutical, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal Pharmaceutical, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal Pharmaceutical, Product Offered and Application
3.8 Global Key Manufacturers of Animal Pharmaceutical, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Animal Pharmaceutical Sales Quantity by Type
4.1.1 Global Animal Pharmaceutical Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Animal Pharmaceutical Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
4.2 Global Animal Pharmaceutical Revenue by Type
4.2.1 Global Animal Pharmaceutical Historical Revenue by Type (2018-2024)
4.2.2 Global Animal Pharmaceutical Forecasted Revenue by Type (2024-2034)
4.2.3 Global Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
4.3 Global Animal Pharmaceutical Price by Type
4.3.1 Global Animal Pharmaceutical Price by Type (2018-2024)
4.3.2 Global Animal Pharmaceutical Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Animal Pharmaceutical Sales Quantity by Application
5.1.1 Global Animal Pharmaceutical Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Animal Pharmaceutical Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
5.2 Global Animal Pharmaceutical Revenue by Application
5.2.1 Global Animal Pharmaceutical Historical Revenue by Application (2018-2024)
5.2.2 Global Animal Pharmaceutical Forecasted Revenue by Application (2024-2034)
5.2.3 Global Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
5.3 Global Animal Pharmaceutical Price by Application
5.3.1 Global Animal Pharmaceutical Price by Application (2018-2024)
5.3.2 Global Animal Pharmaceutical Price Forecast by Application (2024-2034)
6 North America
6.1 North America Animal Pharmaceutical Sales by Company
6.1.1 North America Animal Pharmaceutical Revenue by Company (2018-2024)
6.1.2 North America Animal Pharmaceutical Sales Quantity by Company (2018-2024)
6.2 North America Animal Pharmaceutical Market Size by Type
6.2.1 North America Animal Pharmaceutical Sales Quantity by Type (2018-2034)
6.2.2 North America Animal Pharmaceutical Revenue by Type (2018-2034)
6.3 North America Animal Pharmaceutical Market Size by Application
6.3.1 North America Animal Pharmaceutical Sales Quantity by Application (2018-2034)
6.3.2 North America Animal Pharmaceutical Revenue by Application (2018-2034)
6.4 North America Animal Pharmaceutical Market Size by Country
6.4.1 North America Animal Pharmaceutical Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Animal Pharmaceutical Revenue by Country (2018-2034)
6.4.3 North America Animal Pharmaceutical Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Animal Pharmaceutical Sales by Company
7.1.1 Europe Animal Pharmaceutical Sales Quantity by Company (2018-2024)
7.1.2 Europe Animal Pharmaceutical Revenue by Company (2018-2024)
7.2 Europe Animal Pharmaceutical Market Size by Type
7.2.1 Europe Animal Pharmaceutical Sales Quantity by Type (2018-2034)
7.2.2 Europe Animal Pharmaceutical Revenue by Type (2018-2034)
7.3 Europe Animal Pharmaceutical Market Size by Application
7.3.1 Europe Animal Pharmaceutical Sales Quantity by Application (2018-2034)
7.3.2 Europe Animal Pharmaceutical Revenue by Application (2018-2034)
7.4 Europe Animal Pharmaceutical Market Size by Country
7.4.1 Europe Animal Pharmaceutical Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Animal Pharmaceutical Revenue by Country (2018-2034)
7.4.3 Europe Animal Pharmaceutical Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Animal Pharmaceutical Sales by Company
8.1.1 China Animal Pharmaceutical Sales Quantity by Company (2018-2024)
8.1.2 China Animal Pharmaceutical Revenue by Company (2018-2024)
8.2 China Animal Pharmaceutical Market Size by Type
8.2.1 China Animal Pharmaceutical Sales Quantity by Type (2018-2034)
8.2.2 China Animal Pharmaceutical Revenue by Type (2018-2034)
8.3 China Animal Pharmaceutical Market Size by Application
8.3.1 China Animal Pharmaceutical Sales Quantity by Application (2018-2034)
8.3.2 China Animal Pharmaceutical Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Animal Pharmaceutical Sales by Company
9.1.1 APAC Animal Pharmaceutical Sales Quantity by Company (2018-2024)
9.1.2 APAC Animal Pharmaceutical Revenue by Company (2018-2024)
9.2 APAC Animal Pharmaceutical Market Size by Type
9.2.1 APAC Animal Pharmaceutical Sales Quantity by Type (2018-2034)
9.2.2 APAC Animal Pharmaceutical Revenue by Type (2018-2034)
9.3 APAC Animal Pharmaceutical Market Size by Application
9.3.1 APAC Animal Pharmaceutical Sales Quantity by Application (2018-2034)
9.3.2 APAC Animal Pharmaceutical Revenue by Application (2018-2034)
9.4 APAC Animal Pharmaceutical Market Size by Region
9.4.1 APAC Animal Pharmaceutical Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Animal Pharmaceutical Revenue by Region (2018-2034)
9.4.3 APAC Animal Pharmaceutical Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal Pharmaceutical Sales by Company
10.1.1 Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Animal Pharmaceutical Market Size by Type
10.2.1 Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Animal Pharmaceutical Market Size by Application
10.3.1 Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Animal Pharmaceutical Market Size by Country
10.4.1 Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Zoetis Animal Pharmaceutical Products and Services
11.1.5 Zoetis Animal Pharmaceutical SWOT Analysis
11.1.6 Zoetis Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Animal Pharmaceutical Products and Services
11.2.5 Merck Animal Pharmaceutical SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Merial
11.3.1 Merial Company Information
11.3.2 Merial Overview
11.3.3 Merial Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merial Animal Pharmaceutical Products and Services
11.3.5 Merial Animal Pharmaceutical SWOT Analysis
11.3.6 Merial Recent Developments
11.4 Elanco
11.4.1 Elanco Company Information
11.4.2 Elanco Overview
11.4.3 Elanco Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Elanco Animal Pharmaceutical Products and Services
11.4.5 Elanco Animal Pharmaceutical SWOT Analysis
11.4.6 Elanco Recent Developments
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Information
11.5.2 Bayer Animal Health Overview
11.5.3 Bayer Animal Health Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Bayer Animal Health Animal Pharmaceutical Products and Services
11.5.5 Bayer Animal Health Animal Pharmaceutical SWOT Analysis
11.5.6 Bayer Animal Health Recent Developments
11.6 Boehringer Ingelheim Vetmedica
11.6.1 Boehringer Ingelheim Vetmedica Company Information
11.6.2 Boehringer Ingelheim Vetmedica Overview
11.6.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Products and Services
11.6.5 Boehringer Ingelheim Vetmedica Animal Pharmaceutical SWOT Analysis
11.6.6 Boehringer Ingelheim Vetmedica Recent Developments
11.7 Virbac
11.7.1 Virbac Company Information
11.7.2 Virbac Overview
11.7.3 Virbac Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Virbac Animal Pharmaceutical Products and Services
11.7.5 Virbac Animal Pharmaceutical SWOT Analysis
11.7.6 Virbac Recent Developments
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Information
11.8.2 Ceva Sante Animale Overview
11.8.3 Ceva Sante Animale Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Ceva Sante Animale Animal Pharmaceutical Products and Services
11.8.5 Ceva Sante Animale Animal Pharmaceutical SWOT Analysis
11.8.6 Ceva Sante Animale Recent Developments
11.9 Vétoquinol
11.9.1 Vétoquinol Company Information
11.9.2 Vétoquinol Overview
11.9.3 Vétoquinol Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Vétoquinol Animal Pharmaceutical Products and Services
11.9.5 Vétoquinol Animal Pharmaceutical SWOT Analysis
11.9.6 Vétoquinol Recent Developments
11.10 Jurox
11.10.1 Jurox Company Information
11.10.2 Jurox Overview
11.10.3 Jurox Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Jurox Animal Pharmaceutical Products and Services
11.10.5 Jurox Animal Pharmaceutical SWOT Analysis
11.10.6 Jurox Recent Developments
11.11 MSD Animal Health Australia
11.11.1 MSD Animal Health Australia Company Information
11.11.2 MSD Animal Health Australia Overview
11.11.3 MSD Animal Health Australia Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 MSD Animal Health Australia Animal Pharmaceutical Products and Services
11.11.5 MSD Animal Health Australia Recent Developments
11.12 PARNELL
11.12.1 PARNELL Company Information
11.12.2 PARNELL Overview
11.12.3 PARNELL Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 PARNELL Animal Pharmaceutical Products and Services
11.12.5 PARNELL Recent Developments
11.13 CAHIC
11.13.1 CAHIC Company Information
11.13.2 CAHIC Overview
11.13.3 CAHIC Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 CAHIC Animal Pharmaceutical Products and Services
11.13.5 CAHIC Recent Developments
11.14 Ringpu Biology
11.14.1 Ringpu Biology Company Information
11.14.2 Ringpu Biology Overview
11.14.3 Ringpu Biology Animal Pharmaceutical Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Ringpu Biology Animal Pharmaceutical Products and Services
11.14.5 Ringpu Biology Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Animal Pharmaceutical Value Chain Analysis
12.2 Animal Pharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Pharmaceutical Production Mode & Process
12.4 Animal Pharmaceutical Sales and Marketing
12.4.1 Animal Pharmaceutical Sales Channels
12.4.2 Animal Pharmaceutical Distributors
12.5 Animal Pharmaceutical Customers
13 Market Dynamics
13.1 Animal Pharmaceutical Industry Trends
13.2 Animal Pharmaceutical Market Drivers
13.3 Animal Pharmaceutical Market Challenges
13.4 Animal Pharmaceutical Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Pharmaceutical Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Vaccine
Table 3. Major Manufacturers of Veterinary Drugs
Table 4. Major Manufacturers of Other
Table 5. Global Animal Pharmaceutical Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Animal Pharmaceutical Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Animal Pharmaceutical Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Animal Pharmaceutical Revenue Market Share by Region (2018-2024)
Table 9. Global Animal Pharmaceutical Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Animal Pharmaceutical Revenue Market Share by Region (2024-2034)
Table 11. Global Animal Pharmaceutical Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 12. Global Animal Pharmaceutical Sales by Region (2018-2024) & (K MT)
Table 13. Global Animal Pharmaceutical Sales Market Share by Region (2018-2024)
Table 14. Global Animal Pharmaceutical Sales by Region (2024-2034) & (K MT)
Table 15. Global Animal Pharmaceutical Sales Market Share by Region (2024-2034)
Table 16. Global Animal Pharmaceutical Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 17. Global Animal Pharmaceutical Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Animal Pharmaceutical Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Animal Pharmaceutical Revenue Share by Manufacturers (2018-2024)
Table 20. Global Animal Pharmaceutical Price by Manufacturers 2018-2024 (USD/MT)
Table 21. Global Key Players of Animal Pharmaceutical, Industry Ranking, 2021 VS 2022
Table 22. Global Animal Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Animal Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Pharmaceutical as of 2022)
Table 24. Global Key Manufacturers of Animal Pharmaceutical, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Animal Pharmaceutical, Product Offered and Application
Table 26. Global Key Manufacturers of Animal Pharmaceutical, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Animal Pharmaceutical Sales Quantity by Type (2018-2024) & (K MT)
Table 29. Global Animal Pharmaceutical Sales Quantity by Type (2024-2034) & (K MT)
Table 30. Global Animal Pharmaceutical Sales Quantity Share by Type (2018-2024)
Table 31. Global Animal Pharmaceutical Sales Quantity Share by Type (2024-2034)
Table 32. Global Animal Pharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Animal Pharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Animal Pharmaceutical Revenue Share by Type (2018-2024)
Table 35. Global Animal Pharmaceutical Revenue Share by Type (2024-2034)
Table 36. Animal Pharmaceutical Price by Type (2018-2024) & (USD/MT)
Table 37. Global Animal Pharmaceutical Price Forecast by Type (2024-2034) & (USD/MT)
Table 38. Global Animal Pharmaceutical Sales Quantity by Application (2018-2024) & (K MT)
Table 39. Global Animal Pharmaceutical Sales Quantity by Application (2024-2034) & (K MT)
Table 40. Global Animal Pharmaceutical Sales Quantity Share by Application (2018-2024)
Table 41. Global Animal Pharmaceutical Sales Quantity Share by Application (2024-2034)
Table 42. Global Animal Pharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Animal Pharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Animal Pharmaceutical Revenue Share by Application (2018-2024)
Table 45. Global Animal Pharmaceutical Revenue Share by Application (2024-2034)
Table 46. Animal Pharmaceutical Price by Application (2018-2024) & (USD/MT)
Table 47. Global Animal Pharmaceutical Price Forecast by Application (2024-2034) & (USD/MT)
Table 48. North America Animal Pharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Animal Pharmaceutical Sales Quantity by Company (2018-2024) & (K MT)
Table 50. North America Animal Pharmaceutical Sales Quantity by Type (2018-2024) & (K MT)
Table 51. North America Animal Pharmaceutical Sales Quantity by Type (2024-2034) & (K MT)
Table 52. North America Animal Pharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Animal Pharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Animal Pharmaceutical Sales Quantity by Application (2018-2024) & (K MT)
Table 55. North America Animal Pharmaceutical Sales Quantity by Application (2024-2034) & (K MT)
Table 56. North America Animal Pharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Animal Pharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Animal Pharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Animal Pharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Animal Pharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Animal Pharmaceutical Sales Quantity by Country (2018-2024) & (K MT)
Table 62. North America Animal Pharmaceutical Sales Quantity by Country (2024-2034) & (K MT)
Table 63. Europe Animal Pharmaceutical Sales Quantity by Company (2018-2024) & (K MT)
Table 64. Europe Animal Pharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Animal Pharmaceutical Sales Quantity by Type (2018-2024) & (K MT)
Table 66. Europe Animal Pharmaceutical Sales Quantity by Type (2024-2034) & (K MT)
Table 67. Europe Animal Pharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Animal Pharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Animal Pharmaceutical Sales Quantity by Application (2018-2024) & (K MT)
Table 70. Europe Animal Pharmaceutical Sales Quantity by Application (2024-2034) & (K MT)
Table 71. Europe Animal Pharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Animal Pharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Animal Pharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Animal Pharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Animal Pharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Animal Pharmaceutical Sales Quantity by Country (2018-2024) & (K MT)
Table 77. Europe Animal Pharmaceutical Sales Quantity by Country (2024-2034) & (K MT)
Table 78. China Animal Pharmaceutical Sales Quantity by Company (2018-2024) & (K MT)
Table 79. China Animal Pharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Animal Pharmaceutical Sales Quantity by Type (2018-2024) & (K MT)
Table 81. China Animal Pharmaceutical Sales Quantity by Type (2024-2034) & (K MT)
Table 82. China Animal Pharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Animal Pharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Animal Pharmaceutical Sales Quantity by Application (2018-2024) & (K MT)
Table 85. China Animal Pharmaceutical Sales Quantity by Application (2024-2034) & (K MT)
Table 86. China Animal Pharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Animal Pharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Animal Pharmaceutical Sales Quantity by Company (2018-2024) & (K MT)
Table 89. APAC Animal Pharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Animal Pharmaceutical Sales Quantity by Type (2018-2024) & (K MT)
Table 91. APAC Animal Pharmaceutical Sales Quantity by Type (2024-2034) & (K MT)
Table 92. APAC Animal Pharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Animal Pharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Animal Pharmaceutical Sales Quantity by Application (2018-2024) & (K MT)
Table 95. APAC Animal Pharmaceutical Sales Quantity by Application (2024-2034) & (K MT)
Table 96. APAC Animal Pharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Animal Pharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Animal Pharmaceutical Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Animal Pharmaceutical Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Animal Pharmaceutical Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Animal Pharmaceutical Sales Quantity by Region (2018-2024) & (K MT)
Table 102. APAC Animal Pharmaceutical Sales Quantity by Region (2024-2034) & (K MT)
Table 103. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Company (2018-2024) & (K MT)
Table 104. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Type (2018-2024) & (K MT)
Table 106. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Type (2024-2034) & (K MT)
Table 107. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Application (2018-2024) & (K MT)
Table 110. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Application (2024-2034) & (K MT)
Table 111. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Animal Pharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Country (2018-2024) & (K MT)
Table 117. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity by Country (2024-2034) & (K MT)
Table 118. Zoetis Company Information
Table 119. Zoetis Description and Overview
Table 120. Zoetis Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 121. Zoetis Animal Pharmaceutical Product and Services
Table 122. Zoetis Animal Pharmaceutical SWOT Analysis
Table 123. Zoetis Recent Developments
Table 124. Merck Company Information
Table 125. Merck Description and Overview
Table 126. Merck Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 127. Merck Animal Pharmaceutical Product and Services
Table 128. Merck Animal Pharmaceutical SWOT Analysis
Table 129. Merck Recent Developments
Table 130. Merial Company Information
Table 131. Merial Description and Overview
Table 132. Merial Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 133. Merial Animal Pharmaceutical Product and Services
Table 134. Merial Animal Pharmaceutical SWOT Analysis
Table 135. Merial Recent Developments
Table 136. Elanco Company Information
Table 137. Elanco Description and Overview
Table 138. Elanco Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 139. Elanco Animal Pharmaceutical Product and Services
Table 140. Elanco Animal Pharmaceutical SWOT Analysis
Table 141. Elanco Recent Developments
Table 142. Bayer Animal Health Company Information
Table 143. Bayer Animal Health Description and Overview
Table 144. Bayer Animal Health Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 145. Bayer Animal Health Animal Pharmaceutical Product and Services
Table 146. Bayer Animal Health Animal Pharmaceutical SWOT Analysis
Table 147. Bayer Animal Health Recent Developments
Table 148. Boehringer Ingelheim Vetmedica Company Information
Table 149. Boehringer Ingelheim Vetmedica Description and Overview
Table 150. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 151. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product and Services
Table 152. Boehringer Ingelheim Vetmedica Animal Pharmaceutical SWOT Analysis
Table 153. Boehringer Ingelheim Vetmedica Recent Developments
Table 154. Virbac Company Information
Table 155. Virbac Description and Overview
Table 156. Virbac Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 157. Virbac Animal Pharmaceutical Product and Services
Table 158. Virbac Animal Pharmaceutical SWOT Analysis
Table 159. Virbac Recent Developments
Table 160. Ceva Sante Animale Company Information
Table 161. Ceva Sante Animale Description and Overview
Table 162. Ceva Sante Animale Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 163. Ceva Sante Animale Animal Pharmaceutical Product and Services
Table 164. Ceva Sante Animale Animal Pharmaceutical SWOT Analysis
Table 165. Ceva Sante Animale Recent Developments
Table 166. Vétoquinol Company Information
Table 167. Vétoquinol Description and Overview
Table 168. Vétoquinol Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 169. Vétoquinol Animal Pharmaceutical Product and Services
Table 170. Vétoquinol Animal Pharmaceutical SWOT Analysis
Table 171. Vétoquinol Recent Developments
Table 172. Jurox Company Information
Table 173. Jurox Description and Overview
Table 174. Jurox Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 175. Jurox Animal Pharmaceutical Product and Services
Table 176. Jurox Animal Pharmaceutical SWOT Analysis
Table 177. Jurox Recent Developments
Table 178. MSD Animal Health Australia Company Information
Table 179. MSD Animal Health Australia Description and Overview
Table 180. MSD Animal Health Australia Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 181. MSD Animal Health Australia Animal Pharmaceutical Product and Services
Table 182. MSD Animal Health Australia Recent Developments
Table 183. PARNELL Company Information
Table 184. PARNELL Description and Overview
Table 185. PARNELL Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 186. PARNELL Animal Pharmaceutical Product and Services
Table 187. PARNELL Recent Developments
Table 188. CAHIC Company Information
Table 189. CAHIC Description and Overview
Table 190. CAHIC Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 191. CAHIC Animal Pharmaceutical Product and Services
Table 192. CAHIC Recent Developments
Table 193. Ringpu Biology Company Information
Table 194. Ringpu Biology Description and Overview
Table 195. Ringpu Biology Animal Pharmaceutical Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 196. Ringpu Biology Animal Pharmaceutical Product and Services
Table 197. Ringpu Biology Recent Developments
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Animal Pharmaceutical Distributors List
Table 201. Animal Pharmaceutical Customers List
Table 202. Animal Pharmaceutical Market Trends
Table 203. Animal Pharmaceutical Market Drivers
Table 204. Animal Pharmaceutical Market Challenges
Table 205. Animal Pharmaceutical Market Restraints
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Pharmaceutical Product Picture
Figure 2. Global Animal Pharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Animal Pharmaceutical Market Share by Type in 2022 & 2034
Figure 4. Vaccine Product Picture
Figure 5. Veterinary Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Animal Pharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Animal Pharmaceutical Market Share by Application in 2022 & 2034
Figure 9. Companion Animal
Figure 10. Poultry
Figure 11. Other
Figure 12. Animal Pharmaceutical Report Years Considered
Figure 13. Global Animal Pharmaceutical Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Animal Pharmaceutical Revenue 2018-2034 (US$ Million)
Figure 15. Global Animal Pharmaceutical Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Animal Pharmaceutical Sales Quantity 2018-2034 (K MT)
Figure 17. Global Animal Pharmaceutical Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Animal Pharmaceutical Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Animal Pharmaceutical Sales Quantity YoY (2018-2034) & (K MT)
Figure 20. North America Animal Pharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Animal Pharmaceutical Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. Europe Animal Pharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Animal Pharmaceutical Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. China Animal Pharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Animal Pharmaceutical Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. APAC Animal Pharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. Middle East, Africa and Latin America Animal Pharmaceutical Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Animal Pharmaceutical Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Animal Pharmaceutical Revenue in 2022
Figure 31. Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
Figure 34. Global Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
Figure 36. North America Animal Pharmaceutical Revenue Market Share by Company in 2022
Figure 37. North America Animal Pharmaceutical Sales Quantity Market Share by Company in 2022
Figure 38. North America Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
Figure 40. North America Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
Figure 42. North America Animal Pharmaceutical Revenue Share by Country (2018-2034)
Figure 43. North America Animal Pharmaceutical Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Animal Pharmaceutical Sales Quantity Market Share by Company in 2022
Figure 47. Europe Animal Pharmaceutical Revenue Market Share by Company in 2022
Figure 48. Europe Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
Figure 50. Europe Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
Figure 52. Europe Animal Pharmaceutical Revenue Share by Country (2018-2034)
Figure 53. Europe Animal Pharmaceutical Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 55. France Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 59. China Animal Pharmaceutical Sales Quantity Market Share by Company in 2022
Figure 60. China Animal Pharmaceutical Revenue Market Share by Company in 2022
Figure 61. China Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
Figure 63. China Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
Figure 65. APAC Animal Pharmaceutical Sales Quantity Market Share by Company in 2022
Figure 66. APAC Animal Pharmaceutical Revenue Market Share by Company in 2022
Figure 67. APAC Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
Figure 69. APAC Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
Figure 71. APAC Animal Pharmaceutical Revenue Share by Region (2018-2034)
Figure 72. APAC Animal Pharmaceutical Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 77. India Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Animal Pharmaceutical Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Animal Pharmaceutical Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Animal Pharmaceutical Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Animal Pharmaceutical Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Animal Pharmaceutical Revenue Share by Country (2018-2034)
Figure 86. Brazil Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Animal Pharmaceutical Revenue (2018-2034) & (US$ Million)
Figure 91. Animal Pharmaceutical Value Chain
Figure 92. Animal Pharmaceutical Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed